BodeyG.P., BuckleyM., SatheY.S.Quantitative relationships between circulating leukocytes and infections in patients with acute leukemia. Ann Intern Med.1966; 64: 328–340.
2.
BodeyG.P.Overview of the problem of infections in the immunocompromised host. Am J Med.1985; 79: 56–61.
3.
RubinM., HathornJ.W., PizzoP.A.Controversies in the management of febrile neutropenic cancer patients. Cancer Invest.1988; 6: 167–184.
4.
HughesW.T., ArmstrongD., BodeyG.P.Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis.1990; 161: 381–396.
5.
TalcottJ.A., FinbergR., MayerR.J.The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med.1988; 148: 2561–2568.
6.
TalcottJ.A., SiegelR.D., FinbergR.Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol.1992; 10: 316–322.
7.
BodeyG.P., FainsteinV., EltingL.S.Beta-lactam regimens for the febrile neutropenic patient. Cancer.1990; 65: 9–16.
8.
JonesP.G., RolstonK.V., FainsteinV.Aztreonam therapy in neutropenic patients with cancer. Am J Med.1986; 81: 243–248.
9.
PizzoP.A., RobichaudK.J., WesleyR.Fever in the pediatric and young adult patient with cancer: a prospective study of 1001 episodes. Medicine.1982; 61: 153–165.
10.
RubensteinE.B., RolstonK., BenjaminR.S.Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer.1993; 71: 3640–3646.
11.
TalcottJ.A., WhalenA., ClarkJ.Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol.1994; 12: 107–114.
12.
MalikI.A., AbbasZ., KarimM.Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet.1992; 339: 1092–1096.
13.
Gardembas-PainM., DesablensB., SensebeL.Home treatment of febrile neutropenia: an empirical oral antibiotic regimen. Ann Oncol.1991; 2: 485–487.
14.
MalikI.A., KhanW.A., AzizZ.Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with non-hematologic neoplasms. Clin Infect Dis.1994; 19: 522–527.
15.
RolstonK.V.I., RubensteinE.B., EltingL.Ambulatory management of febrile episodes in low-risk neutropenic patients. In: Programs and Abstracts of the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy, San Francisco Calif. 1995: 333. Abstract 2235.
16.
LauR.C., DoyleJ.J., FreedmanM.H.Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics. Pediatr Hematol Oncol.1994; 11: 417–421.
17.
BashR.O., KatzJ.A., CashJ.V.Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer.1994; 74: 189–196.
18.
MalikI.A., KhanW.A., KarimM.Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med.1995; 98: 224–231.
19.
GilbertC., MeisenbergB., VredenburghJ.Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. J Clin Oncol.1994; 12: 1005–1011.
20.
American Society of Clinical Oncology.Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol.1994; 12: 2471–2508.
21.
MayordomoJ.I., RiveraF., Diaz-PuenteM.T.Improving treatment of chemo-therapy-induced neutropenic fever by ad-ministration of colony-stimulating factors. J Natl Cancer Inst.1995; 87: 803–808.
22.
FreifeldA., PizzoP.Colony-stimulating factors and neutropenia: intersection of data and clinical relevance. J Natl Cancer Inst.1995; 87: 781–782.
23.
McLinnS.E., MoskalM., GoldfarbJ.Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother.1994; 38: 315–318.
